Sanofi Income from Continuous Operations 2010-2024 | SNY

Sanofi income from continuous operations for the twelve months ending December 31, 2024 was $6.010B, a 2.15% increase year-over-year.

  • Sanofi annual income from continuous operations for 2024 was $6.01B, a 2.15% increase from 2023.
  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.
  • Sanofi annual income from continuous operations for 2022 was $8.939B, a 20.33% increase from 2021.

Sanofi Income from Continuous Operations 2010-2024 | SNY

  • Sanofi annual income from continuous operations for 2024 was $6.01B, a 2.15% increase from 2023.
  • Sanofi annual income from continuous operations for 2023 was $5.883B, a 34.18% decline from 2022.
  • Sanofi annual income from continuous operations for 2022 was $8.939B, a 20.33% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B